A vast number of preclinical and clinical studies have provided evidence for the potential role of GLP-1R agonists in modulating reward-seeking of food, alcohol, cocaine, and amphetamine, offering the possibility of a novel therapeutic alternative for treating addiction [112]
CONFLICT OF INTEREST STATEMENT All authors are employees and shareholders of Novo Nordisk A/S
If a Tampa program is still marketing broad, low-cost "compounded semaglutide" for everyone in 2026 without an individualized reason, ask them directly how that squares with the FDA's resolved-shortage determination
In addition to these factors, nutritional deficiencies often accompanying rapid weight loss can exacerbate hair loss
GLP-1 medications are groundbreaking medications that can transform your weight loss journey
Gastroschisis and Maternal Intake of Phytoestrogens